Spots Global Cancer Trial Database for lymphangioleiomyomatosis
Every month we try and update this database with for lymphangioleiomyomatosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Lymphangioleiomyomatosis, a Study on Cathepsin K | NCT05323370 | Lymphangioleiom... Tuberous Sclero... | 24h urine urine sample | 18 Years - | University Hospital, Tours | |
Pulmonary Hypertension in Lymphangioleiomyomatosis | NCT00960895 | Lymphangioleiom... Pulmonary Hyper... | 18 Years - | Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | ||
National Lymphangioleiomyomatosis Registry, France | NCT01484236 | Lymphangioleiom... | 18 Years - | Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | ||
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases | NCT00366509 | Pulmonary Disea... Oropharyngeal D... Lymphangioleiom... Pulmonary Fibro... Asthma Sarcoidosis | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
Discovery of Sirolimus Sensitive Biomarkers in Blood | NCT03304678 | Lymphangioleiom... | Sirolimus 2mg | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
The Genotype and Phenotype of Lymphangioleiomyomatosis | NCT06405997 | Sporadic Lympha... TSC-associated ... | 18 Years - | National Taiwan University Hospital | ||
A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis | NCT01059318 | Lymphangioleiom... | Everolimus | 18 Years - | Novartis | |
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) | NCT06160310 | Tuberous Sclero... Lymphangioleiom... | - | Children's Hospital Medical Center, Cincinnati | ||
A National Registry on Chinese Patients With Lymphangioleiomyomatosis | NCT03193892 | Pulmonary Funct... | - | Peking Union Medical College Hospital | ||
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) | NCT06160310 | Tuberous Sclero... Lymphangioleiom... | - | Children's Hospital Medical Center, Cincinnati | ||
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM | NCT00490789 | Tuberous Sclero... Lymphangioleiom... | sirolimus | 18 Years - 65 Years | Cardiff University | |
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients | NCT02859194 | Interstitial Pu... COPD (Chronic O... Bronchiectasis Lymphangioleiom... Primary Pulmona... ARDS (Acute Res... | Veno-veno-arter... | 20 Years - 80 Years | Yonsei University | |
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma | NCT02325505 | Tuberous Sclero... Lymphangioleiom... Angiomyolipoma | - | InCor Heart Institute | ||
TSC Biosample Repository and Natural History Database | NCT05676099 | Tuberous Sclero... Lymphangioleiom... | Phlebotomy Buccal (cheek) ... Genetic Testing Tissue donation... | - | National Tuberous Sclerosis Association | |
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM | NCT00490789 | Tuberous Sclero... Lymphangioleiom... | sirolimus | 18 Years - 65 Years | Cardiff University | |
Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis | NCT01687179 | Lymphangioleiom... | "Sirolimus" and... "Sirolimus" and... | 18 Years - 85 Years | Brigham and Women's Hospital | |
Study of the Disease Process of Lymphangioleiomyomatosis | NCT00001465 | Lung Disease Pneumothorax Tuberous Sclero... Lymphangioleiom... | Toshibia Aquili... | 16 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) | NCT02654340 | Hypomelanotic M... Facial Angiofib... Shagreen Patche... Ungual Fibromas Cortical Dyspla... Cardiac Rhabdom... Lymphangioleiom... Renal Angiomyol... Subependymal Gi... | 2 Years - 50 Years | CENTOGENE GmbH Rostock | ||
Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis | NCT04577937 | Lymphangioleiom... Sleep Disorder Sleep Apnea Syn... Hypopnea Syndro... | LAM patients un... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
Feasibility of [11C]Acetate-PET in LAM and TSC | NCT05467397 | Lymphangioleiom... Tuberous Sclero... | [11C]acetate | 18 Years - | Brigham and Women's Hospital | |
Characterizing LAM With 11C-Choline PET/CT | NCT05087134 | Lymphangioleiom... | 11C-Choline | 18 Years - 80 Years | Peking Union Medical College Hospital | |
Safety and Durability of Sirolimus for Treatment of LAM | NCT02432560 | Lymphangioleiom... | Sirolimus Everolimus | 18 Years - | University of Cincinnati | |
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) | NCT02654340 | Hypomelanotic M... Facial Angiofib... Shagreen Patche... Ungual Fibromas Cortical Dyspla... Cardiac Rhabdom... Lymphangioleiom... Renal Angiomyol... Subependymal Gi... | 2 Years - 50 Years | CENTOGENE GmbH Rostock | ||
Pulmonary Rehabilitation in Lymphangioleiomyomatosis | NCT02009241 | Lymphangioleiom... | Pulmonary Rehab... | - | University of Sao Paulo General Hospital | |
A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) | NCT03062943 | Lymphangioleiom... | Nintedanib | 18 Years - | IRCCS Multimedica | |
Efficacy and Safety of Sirolimus in LAM | NCT00414648 | Lymphangioleiom... | Sirolimus Placebo | 18 Years - | University of Cincinnati | |
Pulmonary Hypertension in Lymphangioleiomyomatosis | NCT00960895 | Lymphangioleiom... Pulmonary Hyper... | 18 Years - | Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | ||
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | NCT01799538 | Lymphangioleiom... | albuterol inhal... albuterol nebul... PFT | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM) | NCT04184193 | Lymphangioleiom... LAM Pulmonary Rehab... | Pulmonary Rehab... | 18 Years - | Schön Klinik Berchtesgadener Land | |
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906 | Lymphangioleiom... Lymphangiomyoma... Pleural Effusio... Ascites | Octreotide | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
Safety of Simvastatin in LAM and TSC | NCT02061397 | Lymphangioleiom... Tuberous Sclero... | Simvastatin Sirolimus Oral ... Everolimus Oral... | 18 Years - | University of Pennsylvania | |
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial | NCT03253913 | Lymphangioleiom... | Sirolimus Resveratrol | 18 Years - | University of Cincinnati | |
A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) | NCT03062943 | Lymphangioleiom... | Nintedanib | 18 Years - | IRCCS Multimedica | |
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases | NCT05727852 | Chronic Respira... Cystic Fibrosis Lymphangioleiom... Hypersensitivit... Interstitial Lu... COPD Bronchial Asthm... | Breath test usi... Portable cardia... Assessment of a... | 18 Years - | I.M. Sechenov First Moscow State Medical University | |
LAM Pilot Study With Imatinib Mesylate | NCT03131999 | Lymphangioleiom... | Imatinib Mesyla... Placebo - Capsu... | 18 Years - | Medical University of South Carolina | |
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906 | Lymphangioleiom... Lymphangiomyoma... Pleural Effusio... Ascites | Octreotide | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
Characterizing LAM With 11C-Choline PET/CT | NCT05087134 | Lymphangioleiom... | 11C-Choline | 18 Years - 80 Years | Peking Union Medical College Hospital | |
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | NCT01799538 | Lymphangioleiom... | albuterol inhal... albuterol nebul... PFT | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) | NCT02654340 | Hypomelanotic M... Facial Angiofib... Shagreen Patche... Ungual Fibromas Cortical Dyspla... Cardiac Rhabdom... Lymphangioleiom... Renal Angiomyol... Subependymal Gi... | 2 Years - 50 Years | CENTOGENE GmbH Rostock | ||
National Lymphangioleiomyomatosis Registry, France | NCT01484236 | Lymphangioleiom... | 18 Years - | Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | ||
Letrozole for Lymphangioleiomyomatosis | NCT01353209 | Lymphangioleiom... | Letrozole Placebo | 18 Years - | University of Cincinnati |